Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cardiovascular Research|April 28, 2016
Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditionsKerry Layne, Paolo Di Giosia, Albert Ferro, et al.
Current Pharmaceutical Design|August 25, 2011
Cognitive decline as a consequence of essential hypertensionDavide Grassi, Livia Ferri, Paola Cheli, et al.
Current Atherosclerosis Reports|April 2, 2024
Cardiovascular Effects of Stimulators of Soluble Guanylate Cyclase Administration: A Meta-analysis of Randomized Controlled TrialsCosimo Andrea Stamerra, Paolo Di Giosia, Paolo Giorgini, et al.
Advances in Pharmacological and Pharmaceutical Sciences|June 7, 2021
Anderson-Fabry Disease: From Endothelial Dysfunction to Emerging TherapiesCosimo A Stamerra, Rita Del Pinto, Paolo di Giosia, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|February 21, 2014
Hyperuricemia and cardiovascular riskDavide Grassi, Giovambattista Desideri, Anna Vittoria Di Giacomantonio, et al.
Current Pharmaceutical Design|November 10, 2015
Air Pollution Exposure and Blood Pressure: An Updated Review of the LiteraturePaolo Giorgini, Paolo Di Giosia, Davide Grassi, et al.
Pharmacological Research|January 30, 2017
Gender differences in cardiovascular prophylaxis: Focus on antiplatelet treatmentPaolo Di Giosia, Gabriella Passacquale, Marco Petrarca, et al.
Current Atherosclerosis Reports|February 16, 2018
Gender Differences in Epidemiology, Pathophysiology, and Treatment of HypertensionPaolo Di Giosia, Paolo Giorgini, Cosimo Andrea Stamerra, et al.
Pageof 3